Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Translational Lung Cancer Research|August 25, 2021
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be doneLorenzo Belluomini, Alessandra Dodi, Alberto Caldart, et al.Anticancer Research|February 27, 2022
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?Chiara Ciccarese, Roberto Iacovelli, Sebastiano Buti, et al.Cells|October 23, 2021
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone UnturnedLorenzo Belluomini, Silvia Teresa Riva, Michele Simbolo, et al.Frontiers in Oncology|November 17, 2022
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancerAlessio Stefani, Geny Piro, Francesco Schietroma, et al.Cancer Immunology, Immunotherapy : CII|November 24, 2020
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" studyVincenzo Di Noia, Ettore D'Argento, Sara Pilotto, et al.Frontiers in Oncology|January 10, 2022
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old FailuresMiriam Grazia Ferrara, Alessio Stefani, Sara Pilotto, et al.Frontiers in Oncology|May 3, 2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future OpportunitiesMiriam Grazia Ferrara, Alessio Stefani, Michele Simbolo, et al.Clinical Lung Cancer|February 9, 2021
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase InhibitorsMiriam Grazia Ferrara, Maurizio Martini, Ettore D'Argento, et al.Therapeutic Advances in Medical Oncology|November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevanceSara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.American Journal of Human Genetics|July 13, 2010
Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotypeSimone Martinelli, Alessandro De Luca, Emilia Stellacci, et al.Pageof 3